Company intelligence / Profile preview

OSA

South San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Osa Biopharmaceuticals is a stealth-mode biotechnology company focused on developing next-generation therapeutics for oncology and inflammatory diseases. The company leverages a proprietary drug discovery platform to target biological pathways that have previously been difficult to drug with conventional methods. Founded by experienced industry veterans, Osa Biopharmaceuticals aims to translate complex biological insights into high-impact small molecule medicines. While specific pipeline details remain largely proprietary, the company is actively advancing several programs through the pre-clinical stage.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on OSA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OSA.

Explore the full profile